​

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

FMS Stock Forecast

Fresenius Medical Care AG & Co. KGaA (FMS) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $17.85, with a high of $24.00 and a low of $11.70. This represents a -34.38% decline from the last price of $27.20.

$10 $14 $18 $22 $26 $30 High: $24 Avg: $17.85 Low: $11.7 Last Closed Price: $27.2

FMS Stock Rating

Fresenius Medical Care AG & Co. KGaA stock's rating consensus is Hold, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (27.78%), 12 Hold (66.67%), 1 Sell (5.56%), and 0 Strong Sell (0.00%).

Hold
Total 18 0 1 12 5 Strong Sell Sell Hold Buy Strong Buy

FMS Price Target Upside V Benchmarks

TypeNameUpside
StockFresenius Medical Care AG & Co. KGaA-34.38%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks11.53%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$27.20$27.20$27.20
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 251141-7
Sep, 251141-7
Aug, 251131-6
Jul, 251131-6
Jun, 25-141-6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2024David MacDonaldTruist Financial$24.00$22.486.76%-11.76%
Jan 02, 2023James Vane-TempestJefferies$11.70$16.34-28.40%-56.99%
Jun 22, 2022Truist Financial$27.00$23.6414.21%-0.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2025UBSSellUnderperformdowngrade
Sep 02, 2025UBSSelldowngrade
Aug 12, 2025Morgan StanleyUnderweightUnderweighthold
May 15, 2025Morgan StanleyUnderweightUnderweighthold
Oct 23, 2024CitigroupNeutralNeutralhold
Jul 31, 2024BarclaysEqual-WeightEqual-Weighthold
May 13, 2024BarclaysEqual-WeightEqual-Weighthold
Jan 02, 2023JefferiesUnderperformdowngrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.98$1.66$1.15$1.70-----
Avg Forecast$2.72$1.98$1.54$1.29$1.47$1.87$2.14$2.27$2.58
High Forecast$2.78$2.02$1.57$1.35$1.56$2.20$2.18$2.32$2.63
Low Forecast$2.67$1.94$1.52$1.24$1.38$1.74$2.09$2.22$2.52
Surprise %-27.21%-16.16%-25.32%31.78%-----

Revenue Forecast

$18B $19B $21B $22B $24B $25B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$17.86B$17.62B$19.40B$19.45B-----
Avg Forecast$21.73B$20.06B$20.67B$21.09B$20.51B$21.26B$22.18B$23.22B$24.15B
High Forecast$22.12B$20.42B$21.02B$21.37B$20.95B$21.38B$22.54B$23.60B$24.55B
Low Forecast$21.44B$19.79B$20.40B$20.64B$19.69B$21.09B$21.80B$22.82B$23.74B
Surprise %-17.82%-12.17%-6.13%-7.74%-----

Net Income Forecast

$400M $600M $800M $1B $1B $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.16B$969.31M$673.40M$499.00M-----
Avg Forecast$1.14B$579.65M$817.72M$899.49M$430.22M$550.14M$627.61M$665.42M$756.24M
High Forecast$1.37B$593.07M$981.27M$1.08B$458.34M$644.70M$641.06M$679.69M$772.45M
Low Forecast$912.00M$569.70M$654.18M$719.59M$404.91M$510.03M$613.67M$650.64M$739.44M
Surprise %2.14%67.22%-17.65%-44.52%-----

FMS Forecast FAQ

Is Fresenius Medical Care AG & Co. KGaA stock a buy?

Fresenius Medical Care AG & Co. KGaA stock has a consensus rating of Hold, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 12 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Fresenius Medical Care AG & Co. KGaA is a neutral investment for most analysts.

What is Fresenius Medical Care AG & Co. KGaA's price target?

Fresenius Medical Care AG & Co. KGaA's price target, set by 18 Wall Street analysts, averages $17.85 over the next 12 months. The price target range spans from $11.7 at the low end to $24 at the high end, suggesting a potential -34.38% change from the previous closing price of $27.2.

How does Fresenius Medical Care AG & Co. KGaA stock forecast compare to its benchmarks?

Fresenius Medical Care AG & Co. KGaA's stock forecast shows a -34.38% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (11.53%).

What is the breakdown of analyst ratings for Fresenius Medical Care AG & Co. KGaA over the past three months?

  • October 2025: 14.29% Strong Buy, 14.29% Buy, 57.14% Hold, 14.29% Sell, 0% Strong Sell.
  • September 2025: 14.29% Strong Buy, 14.29% Buy, 57.14% Hold, 14.29% Sell, 0% Strong Sell.
  • August 2025: 16.67% Strong Buy, 16.67% Buy, 50.00% Hold, 16.67% Sell, 0% Strong Sell.

What is Fresenius Medical Care AG & Co. KGaA’s EPS forecast?

Fresenius Medical Care AG & Co. KGaA's average annual EPS forecast for its fiscal year ending in December 2024 is $1.47, marking a -13.53% decrease from the reported $1.7 in 2023. Estimates for the following years are $1.87 in 2025, $2.14 in 2026, $2.27 in 2027, and $2.58 in 2028.

What is Fresenius Medical Care AG & Co. KGaA’s revenue forecast?

Fresenius Medical Care AG & Co. KGaA's average annual revenue forecast for its fiscal year ending in December 2024 is $20.51B, reflecting a 5.42% increase from the reported $19.45B in 2023. The forecast for 2025 is $21.26B, followed by $22.18B for 2026, $23.22B for 2027, and $24.15B for 2028.

What is Fresenius Medical Care AG & Co. KGaA’s net income forecast?

Fresenius Medical Care AG & Co. KGaA's net income forecast for the fiscal year ending in December 2024 stands at $430.22M, representing a -13.78% decrease from the reported $499M in 2023. Projections indicate $550.14M in 2025, $627.61M in 2026, $665.42M in 2027, and $756.24M in 2028.